New York State Common Retirement Fund Macrogenics Inc Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Macrogenics Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 5,244 shares of MGNX stock, worth $17,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,244
Previous 23,444
77.63%
Holding current value
$17,095
Previous $100,000
83.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding MGNX
# of Institutions
132Shares Held
55.4MCall Options Held
215KPut Options Held
238K-
Bellevue Group Ag Kuesnacht, V89.93MShares$32.4 Million0.55% of portfolio
-
Armistice Capital, LLC New York, NY6.26MShares$20.4 Million0.34% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$17.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.36MShares$14.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$11.5 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $200M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...